Back to funds
View filing
DCF Advisers, LLC
hedge fundUpdated 32 days agoManaged by Dcf Advisers, Llc • Latest filing Q2 2026
Portfolio value
$565.8M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
67.6%
Weight of largest holdings
Annualized return
35.0%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $163.4M |
| Q2 2023 | $189.3M |
| Q3 2023 | $183.6M |
| Q4 2023 | $184.3M |
| Q1 2024 | $203M |
| Q2 2024 | $194.1M |
| Q3 2024 | $250.2M |
| Q4 2024 | $206.7M |
| Q1 2025 | $208.9M |
| Q2 2025 | $215.8M |
| Q3 2025 | $311.2M |
| Q4 2025 | $372.8M |
| Q1 2026 | $375.1M |
| Q2 2026 | $565.8M |
Top holdings
93 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | Q QQQ INVESCO QQQ TR | $142.2M | 193.1K | 25.13% | — |
| 2 | M MU MICRON TECHNOLOGY INC | $115.4M | 100.0K | 20.40% | — |
| 3 | G GOOGN ALPHABET INC | $19.1M | 54.0K | 3.37% | — |
| 4 | S SPY STATE STR SPDR S&P 500 ETF T | $18.7M | 25.0K | 3.30% | — |
| 5 | A AMD ADVANCED MICRO DEVICES INC | $16.8M | 29.0K | 2.98% | — |
| 6 | M MU MICRON TECHNOLOGY INC | $14.4M | 12.5K | 2.55% | — |
| 7 | A AMZN AMAZON COM INC | $14.1M | 59.3K | 2.50% | — |
| 8 | A ARGX ARGENX SE | $13.2M | 14.2K | 2.33% | — |
| 9 | C CRVS CORVUS PHARMACEUTICALS INC | $9.5M | 637.5K | 1.68% | — |
| 10 | H HELP CYBIN INC | $9.5M | 1.43M | 1.68% | — |
| 11 | T TEVJF TEVA PHARMACEUTICAL INDS LTD | $8.6M | 254.5K | 1.52% | — |
| 12 | M MRVL MARVELL TECHNOLOGY INC | $8.2M | 27.5K | 1.45% | — |
| 13 | I IAU ISHARES GOLD TR | $7.6M | 100.0K | 1.33% | — |
| 14 | B BAC-PS BANK OF AMER CORP | $6.8M | 119.5K | 1.20% | — |
| 15 | R REGN REGENERON PHARMACEUTICALS | $5.8M | 9.3K | 1.02% | — |
| 16 | E ET-PI ENERGY TRANSFER L P | $5.7M | 300.5K | 1.02% | — |
| 17 | V VRTX VERTEX PHARMACEUTICALS INC | $5.7M | 11.5K | 1.01% | — |
| 18 | G GLD SPDR GOLD TR | $5.2M | 14.0K | 0.91% | — |
| 19 | C C-PR CITIGROUP INC | $5M | 36.0K | 0.89% | — |
| 20 | N NAMSW NEWAMSTERDAM PHARMA COMPANY | $4.8M | 141.0K | 0.84% | — |